Correspondence on 'Safety and tolerability of nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from the SENSCIS trial'. Issue 12 (6th October 2020)

Record Type:: Journal Article
Title:: Correspondence on 'Safety and tolerability of nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from the SENSCIS trial'. Issue 12 (6th October 2020)
Main Title:: Correspondence on 'Safety and tolerability of nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from the SENSCIS trial'
Authors:: Bredemeier, Markus
Abstract:
Is Part Of:: Annals of the rheumatic diseases. Volume 81:Issue 12(2022)
Journal:: Annals of the rheumatic diseases
Issue:: Volume 81:Issue 12(2022)
Issue Display:: Volume 81, Issue 12 (2022)
Year:: 2022
Volume:: 81
Issue:: 12
Issue Sort Value:: 2022-0081-0012-0000
Page Start:: e250
Page End:: e250
Publication Date:: 2020-10-06
Subjects:: scleroderma -- systemic -- pulmonary fibrosis -- therapeutics
Rheumatism -- Periodicals
616.723005
Journal URLs:: http://ard.bmjjournals.com/ ↗
http://www.pubmedcentral.nih.gov/tocrender.fcgi?journal=149&action=archive ↗
http://www.bmj.com/archive ↗
http://gateway.ovid.com/server3/ovidweb.cgi?T=JS&MODE=ovid&D=ovft&PAGE=titles&SEARCH=annals+of+the+rheumatic+diseases.tj&NEWS=N ↗
DOI:: 10.1136/annrheumdis-2020-218911 ↗
Languages:: English
ISSNs:: 0003-4967
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 24339.xml